3Rothenberg AB, Berdon WE, D'Angio GJ, et al. The association between neuroblastoma and opsoclonus-myoclonus syndrome: a historical review [ J ]. Pediatr Radial ,2009,39:723-726.
4Park JR, Eggert A, Caron H. Neuroblastima: biology, prognosis and treatment[J]. Pediatr Clin North AM,2008,55:97-120.
5Gorman MP. Update on diagnosis, treatment, and prognosis in opsoclonus-myoclonus-ataxia syndrome [ J ]. Curr Opin Pediatr, 2010,22:745-750.
6Brunklaus A, Pohl K, Zuberi SM, et al. Investigating neuroblastoma in childhood opsoclonus-myoclonus syndrome [ J ]. Arch Dis Child ,2012,97:461-463.
7Matthay KK, Blaes F, Hero B, et al. Opsoclonus myoelonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004[ J]. Cancer Lett,2005 ,228 :275-282.
8Raffaghello L, Fuhlhuber V, Bianchi G, et al. Role of BAFF in opsoclonus-myoclonus syndrome, a bridge between cancer and autoimmunity[ J ]. J Leukoc Bio1,2013,94 : 183-191.
9Ketterl TG, Messinger YH, Niess DR, et al. Ofatumumab for refractory opsoclonus-myoclonus syndrome following treatment of neuroblastoma[J]. Pediatr Blood Cancer,2013,60:E163-165.
10Krug P, Schleiermaeher G, Michon J, et al. Opsoclonus- myoclonus in children associated or not with neuroblastoma [ J ]. Eur J Paediatr Neural.2010,14:400-409.
